Product Name : Seratrodast 50% DC Granules
Dosage Form : Tablets
Dose : 80mg
Reference Product : Seretra
API : DMF; Dossier — CTD : Available
Originator : Takeda
Seratrodast (development name, AA-2414; marketed originally as Bronica) is a thromboxane A2(TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma. It was the first TP receptor antagonist that was developed as an anti-asthmatic drug and received marketing approval in Japan in 1997.
Seratrodast (development name, AA-2414; marketed originally as Bronica)[2] is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma.[3][4] It was the first TP receptor antagonist that was developed as an anti-asthmatic drug and received marketing approval in Japan in 1997.[5] As of 2017 seratrodast was marketed as Bronica in Japan, and as Changnuo, Mai Xu Jia, Quan Kang Nuo in China.